首页> 外文期刊>Genetic testing and molecular biomarkers >Investigation of KIF6 Trp719Arg in a Case-Control Study of Coronary Artery Disease in Western Indians
【24h】

Investigation of KIF6 Trp719Arg in a Case-Control Study of Coronary Artery Disease in Western Indians

机译:西部印第安人冠状动脉疾病病例对照研究中KIF6 Trp719Arg的调查

获取原文
获取原文并翻译 | 示例
       

摘要

Background: A single-nucleotide polymorphism Trp719Arg (rs20455T>C) in the kinesin-like protein 6 (KIF6), which is a protein involved in intracellular transport, has been shown to predict increased coronary artery disease (CAD) risk and event reduction during statin therapy. Aim: In the current study, we have evaluated the association of the variant Trp719Arg with CADon fatal myocardial infarction (MI) in Western Indians. Methods: Genotyping for Trp719Arg was done by an allele-specific real-time assay in 227 cases with confirmed CAD and 150 controls. Results: We have found that the KIF6 719 Arg carriers were not at a significantly higher risk for CADon-fatal MI in this case-control study of an Indo-European population from Western India (Unadjusted odds ratio [OR] 0.767 95% confidence interval [CI] 0.573-1.027 for 719Arg carriers). When the genotypes were further tested to determine association with prevalent myocardial infarction as the event versus CAD, no association was seen in a univariate analysis (MI vs. CAD OR 0.804 95% CI 0.543-1.189; MI vs. Controls OR 0.702 95% CI 0.482-1.021). Conclusion: In summary, carriers of the KIF6 719Arg allele were not at increased risk of CADon-fatal MI in a case-control study of Indians (Indo-Europeans) living in Western India.
机译:背景:驱动蛋白样蛋白6(KIF6)中的一种单核苷酸多态性Trp719Arg(rs20455T> C)是一种参与细胞内运输的蛋白,已被证明可预测冠心病(CAD)风险增加和事件发生期间的事件减少他汀类药物疗法。目的:在当前的研究中,我们评估了Trp719Arg变体与西印度裔CAD /非致命性心肌梗塞(MI)的关联。方法:通过等位基因特异性实时分析法对227例确诊为CAD的病例和150例对照进行Trp719Arg基因分型。结果:我们发现,在来自印度西部印度裔欧洲人口的病例对照研究中,KIF6 719 Arg携带者的CAD /非致死性MI风险没有显着增加(未调整优势比[OR] 0.767 95% 719Arg载波的置信区间[CI] 0.573-1.027)。当进一步测试基因型以确定与普遍的心肌梗死的关联性时,与事件相比,在单因素分析中未见关联(MI vs. CAD或0.804 95%CI 0.543-1.189; MI vs.对照或0.702 95%CI 0.482-1.021)。结论:总之,在居住在印度西部的印度人(印欧语系)进行的病例对照研究中,KIF6 719Arg等位基因的携带者没有CAD /非致命性MI的风险增加。

著录项

  • 来源
    《Genetic testing and molecular biomarkers》 |2011年第12期|p.883-886|共4页
  • 作者单位

    Super Religare Laboratories Ltd., Research and Development, Goregaon (W), Mumbai, India;

    Asian Heart Institute, Bandra (E), Mumbai, India;

    V.T. Shah Clinic and Diagnostic Centre, Matunga, Mumbai, India;

    Super Religare Laboratories Ltd., Research and Development, Goregaon (W), Mumbai, India;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 13:19:29

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号